Good Manufacturing Practice (GMP) is part of the quality assurance system for the production of medicinal products for human use and active substances.
Good Distribution Practice (GDP) is based on the Guidelines of 5 November 2013 on "Good Distribution Practice for Medicinal Products for Human Use" published by the European Commission. They have two main objectives: on the one hand, to prevent falsified medicines from entering the legal distribution chain, and on the other hand, to ensure control of the distribution chain and, consequently, to maintain the quality and integrity of medicinal products.
Quality Austria offers assessments on both topics. These audits qualityAustria ensures optimal preparation for any upcoming inspections carried out by the competent national authorities responsible for the regulation of medicinal products.




